Takeda Pharmaceutical to cut sales jobs in Japan, sources say – Reuters UK

TOKYO (Reuters) – Takeda Pharmaceutical Co (4502.T) is looking to cut sales jobs in Japan in its latest restructuring effort, as it overhauls domestic business following its $59 billion purchase of Shire Plc, sources familiar with the company’s plans said. FILE PHOTO: People walk past the new headquarters of Takeda Pharmaceutical Co in Tokyo, Japan,…

Takeda Pharmaceutical to cut sales jobs in Japan, sources say – Reuters UK

TOKYO (Reuters) – Takeda Pharmaceutical Co (4502.T) is looking to cut sales jobs in Japan in its latest restructuring effort, as it overhauls domestic business following its $59 billion purchase of Shire Plc, sources familiar with the company’s plans said. FILE PHOTO: People walk past the new headquarters of Takeda Pharmaceutical Co in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-HoonMajor pharma companies in Japan have scaled down their sales forces to cope with a shrinking market and cuts in drug prices imposed by the national health system. The layoffs by Takeda, Japan’s biggest drug maker, will be focused on sales positions, two industry sources told Reuters
Read More From Publisher